Email us connect@hepdconnect.org
Welcome to Hepatitis Delta Connect!
A dedicated program of the Hepatitis B Foundation to increase awareness about hepatitis delta, a serious virus that coinfects hepatitis B patients, promote screening and testing, and provide information and support for those affected.
Clinical Trial Finder - Find A Clinical Trial Near You!
We've educated 13,000 people in 111 countries!
News & Updates
September Blog Post: New Hepatitis Delta Treatment Approved by European Commission
May Blog Post: Does Hepatitis Delta Increase My Risk for Liver Cancer?
View our recent webinar, Hepatitis Delta Treatment Endpoints: How Do We Measure Success in the Era of Emerging Therapies recording here.
Phase 3 clinical trials are now open for hepatitis delta, click here for more information.
11/17/20: Eiger Announces Positive Peginterferon Lambda-Lonafarnib Combination End-of-Study Results from Phase 2 LIFT HDV Study at the Liver Meeting Digital Experience 2020
11/16/20: Eiger Announces Case Studies Demonstrating Regression of Liver Fibrosis Following 48 Weeks of Therapy with Peginterferon Lambda in Patients with Chronic HDV Infection at the Liver Meeting Digital Experience 2020
10/7/20: Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?
9/17/20: Hepcludex Launched in Germany, France, and Austria
8/31/20: End of Treatment Results Presented for Lambda-Interferon + Lonafarnib Combination Phase 2 Study
8/5/20 Hepcludex approved by European Commission
Get Connected
